The FHIT gene has many hallmarks of a tumor-suppressor gene and is involved in a large variety of
cancers. We treated A/J mice and (C57BL/6J x 129/SvJ)F1 (B6/129 F1) mice, either wild-type or FHIT+/-, with multiple doses of
benzo[a]pyrene (B[a]P) by gavage. B[a]P caused a time-related increase of micronuclei in peripheral blood erythrocytes. Both A/J and B6/129 F1 mice, irrespective of their FHIT status, were sensitive to induction of forestomach
tumors, whereas B[a]P induced glandular stomach
hyperplasia and a high multiplicity of lung
tumors in A/J mice only. Preneoplastic lesions of the uterus were more frequent in FHIT+/- mice. B6/129 F1 mice underwent spontaneous
alopecia areata and hair bulb cell apoptosis, which were greatly accelerated either by FHIT heterozygosity or by B[a]P treatment, thus suggesting that FHIT plays a role in the pathogenesis of
alopecia areata. The
oral administration of either
budesonide or
N-acetyl-L-cysteine (NAC) inhibited the occurrence of this inflammatory
skin disease. In addition, these agents prevented B[a]P-induced glandular stomach
hyperplasia and decreased the size of both forestomach
tumors and lung
tumors in A/J mice.
Budesonide also attenuated lung
tumor multiplicity. In B6/129 F1 mice, NAC significantly decreased the
proliferating cell nuclear antigen in lung
tumors. Both
budesonide and NAC inhibited B[a]P-induced forestomach
tumors and preneoplastic lesions of the respiratory tract in B6/129 F1 mice. In conclusion, heterozygosity for FHIT affects susceptibility of mice to spontaneous
alopecia areata and B[a]P-induced preneoplastic lesions of the uterus and does not alter responsiveness to
budesonide and NAC.